Hospital de Clínicas de Ribeirão Preto

Ribeirão Preto, São Paulo 14051-140

1 studies enrolling now · 3 studies all time

What they study most

Atopic Dermatitis, Breast Cancer, Eczema, Medullary Thyroid Cancer

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation
• Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer — Running, not enrolling
• A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer — Running, not enrolling